Lexicon Pharmaceuticals
LXRX
#6799
Rank
$0.77 B
Marketcap
$1.74
Share price
-4.40%
Change (1 day)
12.26%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total assets

Total assets on the balance sheet as of June 2026 : $0.25 Billion USD

According to Lexicon Pharmaceuticals 's latest financial reports the company's total assets are $0.25 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lexicon Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31$0.18 B-38.01%
2024-12-31$0.29 B30.07%
2023-12-31$0.22 B18.08%
2022-12-31$0.19 B41.92%
2021-12-31$0.13 B-32.82%
2020-12-31$0.20 B-51.21%
2019-12-31$0.41 B47.01%
2018-12-31$0.28 B-34.91%
2017-12-31$0.43 B-8.22%
2016-12-31$0.47 B-27.05%
2015-12-31$0.65 B38.31%
2014-12-31$0.47 B71.93%
2013-12-31$0.27 B-26.26%
2012-12-31$0.37 B-13.64%
2011-12-31$0.43 B17.34%
2010-12-31$0.36 B42.33%
2009-12-31$0.25 B-1.43%
2008-12-31$0.26 B-29.19%
2007-12-31$0.36 B94.09%
2006-12-31$0.19 B-13.01%
2005-12-31$0.21 B3.18%
2004-12-31$0.21 B-25.41%
2003-12-31$0.28 B40.85%
2002-12-31$0.20 B-15.92%
2001-12-31$0.23 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Thermo Fisher Scientific
TMO
$113.17 B 45,158.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$6.55 B 2,522.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$41.73 B 16,588.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
$1.26 B 405.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$2.18 B 774.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.46 B 84.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
$0.37 B 50.20%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$11.72 B 4,588.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$6.31 M-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA